Vancouver, BC, Canada - (NewMediaWire) - September 3, 2020 - Neovasc Inc. (Neovasc or the Company) (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on September 3, 2020 in Vancouver,...
Read MoreVANCOUVER and MINNEAPOLIS, MN - (NewMediaWire) - August 17, 2020 - Neovasc Inc. (Neovasc or the Company) (NASDAQ, TSX: NVCN) announced today that Strul Medical Group LLC (SMG) exercised 501,000 of the remaining 1,149,910 common share purchase warrants (the May Warrants) issued pursuant to a...
Read MoreVANCOUVER and MINNEAPOLIS - (NewMediaWire) - August 13, 2020 - Neovasc, Inc.(NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), today provided a corporate update on progress towards its value creation strategies.Fred Colen, Chief Executive Officer of Neovasc, commented, "We are pleased to provide acorporate updateto...
Read MoreVancouver, Canada - (NewMediaWire) - August 12, 2020 - Neovasc Inc. (Neovasc or the Company) (NASDAQ: NVCN / TSX: NVCN) announced today that it has closed its previously announced registered direct offering (the Offering)priced at-the-market under the Nasdaq rules of an aggregate of 4,532,772 common shares at a purchase...
Read MoreVancouver - (NewMediaWire) - August 10, 2020 - Neovasc Inc. (Neovasc or the Company) (NASDAQ: NVCN / TSX: NVCN) announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 4,532,772 common shares at a...
Read MoreNASDAQ, TSX: NVCN VANCOUVER and MINNEAPOLIS, August 6, 2020 – Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, today reported financial results for...
Read MoreNASDAQ, TSX: NVCN VANCOUVER, CA, MINNEAPOLIS, US and FRANKFURT, DE, July 24, 2020 – Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that the Neovasc Reducer™ (the “Reducer”) was featured in a supplement titled: “Volkskrankheiten” or “Common Diseases” in Frankfurter Allgemeine Zeitung (FAZ),...
Read MoreNASDAQ, TSX: NVCN VANCOUVER and MINNEAPOLIS, – July 23, 2020 – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that Strul Medical Group LLC (“SMG”) exercised 1,424,049 of the 2,573,959 common share purchase warrants (the “May Warrants”) issued pursuant to a Securities Purchase...
Read More